Sulfo-cyanine3 azide potassium

Cat. No.: HY-D1274C Purity: 98.08%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Sulfo-cyanine3 azide potassium is an azide cyanine dye and fluorescent probe (Ex/Em=548/563 nm). Sulfo-cyanine3 azide potassium can be used for synthesis of fused tricyclic heterocycles, producing immunostimulatory agents.

For research use only. We do not sell to patients.

Sulfo-cyanine3 azide potassium Chemical Structure

Size	Price	Stock	Quantity
1 mg	USD 160	In-stock	Estimated Time of Arrival: December 31
5 mg	USD 410	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 650	In-stock	Estimated Time of Arrival: December 31
50 mg		Get quote
100 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Sulfo-cyanine3 azide potassium:

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	Sulfo-cyanine3 azide potassium is an azide cyanine dye and fluorescent probe (Ex/Em=548/563 nm). Sulfo-cyanine3 azide potassium can be used for synthesis of fused tricyclic heterocycles, producing immunostimulatory agents^[1]^[2].
Molecular Weight	736.94
Formula	C₃₃H₄₁KN₆O₇S₂
Appearance	Solid
Color	Brown to reddish brown
SMILES	[N-]=[N+]=NCCCNC(CCCCCN1C2=CC=C(S(=O)(O[K])=O)C=C2C(C)(C)/C1=C\C=C\C3=[N+](C)C4=C(C3(C)C)C=C(S(=O)([O-])=O)C=C4)=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	-20°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Purity & Documentation	Purity: 98.08% Select Batch: Data Sheet (269 KB) SDS (251 KB) COA (252 KB) LCMS (119 KB) Handling Instructions (2659 KB)
References	[1]. Hsieh PY, et al. Harnessing Fluorescent Moenomycin A Antibiotics for Bacterial Cell Wall Imaging Studies. Chembiochem. 2021 Dec 10;22(24):3462-3468. [Content Brief] [2]. David, Sunil A, et al. Preparation of fused tricyclic heterocycles as therapeutic compounds and methods of use thereof: World Intellectual Property Organization, WO2020009946[P]. 2020-01-09. [3]. David, et al. Preparation of fused tricyclic heterocycles as therapeutic compounds and methods of use thereof: World Intellectual Property Organization, WO2020009946[P]. 2020-01-09.